Guidelines International Network | Guidelines International Network (GIN)

Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline

MeSH Terms: Prostatic Neoplasms (C04.588.945.440.770); Diagnostic Imaging (E01.370.350)
Guideline Contact: [email protected]
Publication Date: 15-Jan-20
Date of Last Evidence Search: 18-Aug
Publication Scope: assessment
Countries of Application: United States
Guideline Publication Status: Published
Languages: English
Authors: ASCO (US)
Publication Year: 2020

MeSH Terms: Atrial fibrillation; Stroke; Anticoagulants; Warfarin; Rivaroxaban; Dabigatran; Apixaban
Guideline Contact: Agency for Care Effectiveness
English Title Translation: NA
Keywords: atrial fibrillation; stroke prevention; anticoagulation; stroke risk; bleeding risk
Date for Review: 28-Nov-28
Publication Date: 28-Nov-23
Expected Publication Date: 28-Nov-23
Methods Applied: GRADE; AGREE-II; Systematic search of guidelines; risk of bias
Publication Scope: prevention
Countries of Application: Singapore
Guideline Publication Status: Published
Languages: English
Authors: Agency for Care Effectiveness Singapore
Publication Year: 2023
Name of Endorsing Organization: Ministry of Health Singapore

MeSH Terms: Public Health Practice (N06.850.780); Mouth Diseases (C07.465); Head and Neck Neoplasms (C04.588.443)
Guideline Contact: Roos Leroy ([email protected])
Publication Scope: management; patient_education; screening; treatment
Countries of Application: Belgium
Guideline Publication Status: Published
Languages: English
Authors: KCE (BE)
Publication Year: 2014

MeSH Terms: Dementia (C10.228.140.380); Geriatric Assessment (N05.715.360.300.360); Health Services for the Aged (N02.421.320); Enteral Nutrition (E02.421.360)
Publication Scope: counselling
Countries of Application: Australia
Guideline Publication Status: Published
Languages: English
Authors: JBI (AU)
Publication Year: 2010

MeSH Terms: Hemoglobin A; Glycosylated (D12.776.422.316.762.380.440); Hemoglobin A; Glycosylated (D12.776.124.400.405.440); Hemoglobin A; Glycosylated (D09.408.375); Diabetes Mellitus; Type 2 (C19.246.300); Therapeutic Uses (D27.505.954); Metformin (D02.078.370.141.450); Thiazolidinediones (D02.886.675.933); Dipeptidyl Peptidase 4 (D23.050.301.264.035.283); Diabetes Mellitus (C19.246); Drug Therapy; Combination (E02.319.310); Dipeptidyl-Peptidase IV Inhibitors (D27.505.696.422.500); Sodium-Glucose Transporter 2 (D12.776.157.530.500.750.750); Sodium-Glucose Transporter 2 (D12.776.543.585.500.750.750); Dipeptidyl-Peptidase IV Inhibitors (D27.505.519.389.745.335)
Guideline Contact: Amir Qaseem ([email protected])
Publication Date: 01/03/2017
Date of Last Evidence Search: 12/2015
Methods Applied: See Publication
Publication Scope: Treatment
Countries of Application: United States
Guideline Publication Status: Inactive
Languages: English
Authors: ACP (US)
Publication Year: 2017